Integrated Proteogenomic Characterization of Clear Cell Renal Cell CarcinomaDavid Clark, Phillip M. Pierorazio, Saravana M. Dhanasekaran et al.|Cell|2019Cited by 775
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Xiaoming Wang et al.|Cell Reports Medicine|2024Cited by 28
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory responseYuanyuan Qiao, Arul M. Chinnaiyan, Jesse W. Wotring et al.|Proceedings of the National Academy of Sciences|2023Cited by 8
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Jing Hu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean C. Tien, Arul M. Chinnaiyan, Yu Chang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1